Publication | Open Access

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Amyloid β-Peptide EnterNeurodegenerative DiseasesAlzheimer's DiseaseMedicineImmunologyDegenerative PathologyProtein MisfoldingNeurologyNeuroscienceNeurodegenerationCentral Nervous SystemAlzheimer DiseaseNeuroimmunologyBrain PathologyProtective MechanismsHealth Sciences